Sphingolipid rheostat alterations related to transformation can be exploited for specific induction of lysosomal cell death in murine and human glioma

Rodrigo Mora, Ivana Dokic, Tim Kees, Christian M. Hüber, Denise Keitel, Renate Geibig, Britta Brügge, Hanswalter Zentgraf, Nathan Ryan Brady, Anne Régnier-Vigouroux

Research output: Contribution to journalArticle

Abstract

The search for cancer cell-specific targets suffers from a lack of integrative approaches that take into account the relative contributions of several mechanisms or pathways involved in cell death. A systematic experimental and computational comparison of murine glioma cells with astrocytes, their nontransformed counterparts, identified differences in the sphingolipid (SL) rheostat linked to an increased lysosomal instability in glioma cells. In vitro and in silico analyses indicate that sphingosine metabolized in lysosomes was preferentially recycled into ceramide, the prodeath member of the rheostat, in astrocytes. In glioma cells, it preferentially was used for production of the prosurvival sphingosine-1-phosphate (S1P). A combination of tumor necrosis factor alpha (TNF-α), lipopolysaccharide (LPS), and interferon gamma (IFN-γ) strongly decreased S1P production that resulted in abnormal lysosome enlargement and cell death associated with mitochondrial dysfunction of glioma cells only. Lack of intracellular S1P in glioma cells was concomitant with protein and lipid accumulation in enlarged lysosomes, indicating a blockade in lysosome recycling, and hence a role for S1P in membrane trafficking. A pharmacological sphingosine kinase inhibitor efficiently replaced the TNF-α, LPS, and IFN-γ combination and killed murine and human glioma cells without affecting astrocytes. Our study provides evidence for a novel mechanism of lysosomal death dependent upon the SL rheostat that can be specifically triggered in glioma cells. It further strengthens the potential of cancer therapies based on specific ceramide pathway alterations.

Original languageEnglish (US)
Pages (from-to)1364-1383
Number of pages20
JournalGLIA
Volume58
Issue number11
DOIs
StatePublished - Aug 15 2010
Externally publishedYes

Fingerprint

Sphingolipids
Glioma
Cell Death
Lysosomes
Astrocytes
Ceramides
Lipopolysaccharides
Tumor Necrosis Factor-alpha
Sphingosine
Interferon-alpha
Computer Simulation
Interferon-gamma
Neoplasms
Pharmacology
Lipids
Membranes
sphingosine 1-phosphate

Keywords

  • Astrocyte
  • Ceramide
  • Glioma
  • Mathematical model
  • Sphingosine-1-phosphate
  • Toxicity

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Neurology

Cite this

Mora, R., Dokic, I., Kees, T., Hüber, C. M., Keitel, D., Geibig, R., ... Régnier-Vigouroux, A. (2010). Sphingolipid rheostat alterations related to transformation can be exploited for specific induction of lysosomal cell death in murine and human glioma. GLIA, 58(11), 1364-1383. https://doi.org/10.1002/glia.21013

Sphingolipid rheostat alterations related to transformation can be exploited for specific induction of lysosomal cell death in murine and human glioma. / Mora, Rodrigo; Dokic, Ivana; Kees, Tim; Hüber, Christian M.; Keitel, Denise; Geibig, Renate; Brügge, Britta; Zentgraf, Hanswalter; Brady, Nathan Ryan; Régnier-Vigouroux, Anne.

In: GLIA, Vol. 58, No. 11, 15.08.2010, p. 1364-1383.

Research output: Contribution to journalArticle

Mora, R, Dokic, I, Kees, T, Hüber, CM, Keitel, D, Geibig, R, Brügge, B, Zentgraf, H, Brady, NR & Régnier-Vigouroux, A 2010, 'Sphingolipid rheostat alterations related to transformation can be exploited for specific induction of lysosomal cell death in murine and human glioma', GLIA, vol. 58, no. 11, pp. 1364-1383. https://doi.org/10.1002/glia.21013
Mora, Rodrigo ; Dokic, Ivana ; Kees, Tim ; Hüber, Christian M. ; Keitel, Denise ; Geibig, Renate ; Brügge, Britta ; Zentgraf, Hanswalter ; Brady, Nathan Ryan ; Régnier-Vigouroux, Anne. / Sphingolipid rheostat alterations related to transformation can be exploited for specific induction of lysosomal cell death in murine and human glioma. In: GLIA. 2010 ; Vol. 58, No. 11. pp. 1364-1383.
@article{fabf9763b6db458f8207be880176c7b6,
title = "Sphingolipid rheostat alterations related to transformation can be exploited for specific induction of lysosomal cell death in murine and human glioma",
abstract = "The search for cancer cell-specific targets suffers from a lack of integrative approaches that take into account the relative contributions of several mechanisms or pathways involved in cell death. A systematic experimental and computational comparison of murine glioma cells with astrocytes, their nontransformed counterparts, identified differences in the sphingolipid (SL) rheostat linked to an increased lysosomal instability in glioma cells. In vitro and in silico analyses indicate that sphingosine metabolized in lysosomes was preferentially recycled into ceramide, the prodeath member of the rheostat, in astrocytes. In glioma cells, it preferentially was used for production of the prosurvival sphingosine-1-phosphate (S1P). A combination of tumor necrosis factor alpha (TNF-α), lipopolysaccharide (LPS), and interferon gamma (IFN-γ) strongly decreased S1P production that resulted in abnormal lysosome enlargement and cell death associated with mitochondrial dysfunction of glioma cells only. Lack of intracellular S1P in glioma cells was concomitant with protein and lipid accumulation in enlarged lysosomes, indicating a blockade in lysosome recycling, and hence a role for S1P in membrane trafficking. A pharmacological sphingosine kinase inhibitor efficiently replaced the TNF-α, LPS, and IFN-γ combination and killed murine and human glioma cells without affecting astrocytes. Our study provides evidence for a novel mechanism of lysosomal death dependent upon the SL rheostat that can be specifically triggered in glioma cells. It further strengthens the potential of cancer therapies based on specific ceramide pathway alterations.",
keywords = "Astrocyte, Ceramide, Glioma, Mathematical model, Sphingosine-1-phosphate, Toxicity",
author = "Rodrigo Mora and Ivana Dokic and Tim Kees and H{\"u}ber, {Christian M.} and Denise Keitel and Renate Geibig and Britta Br{\"u}gge and Hanswalter Zentgraf and Brady, {Nathan Ryan} and Anne R{\'e}gnier-Vigouroux",
year = "2010",
month = "8",
day = "15",
doi = "10.1002/glia.21013",
language = "English (US)",
volume = "58",
pages = "1364--1383",
journal = "GLIA",
issn = "0894-1491",
publisher = "John Wiley and Sons Inc.",
number = "11",

}

TY - JOUR

T1 - Sphingolipid rheostat alterations related to transformation can be exploited for specific induction of lysosomal cell death in murine and human glioma

AU - Mora, Rodrigo

AU - Dokic, Ivana

AU - Kees, Tim

AU - Hüber, Christian M.

AU - Keitel, Denise

AU - Geibig, Renate

AU - Brügge, Britta

AU - Zentgraf, Hanswalter

AU - Brady, Nathan Ryan

AU - Régnier-Vigouroux, Anne

PY - 2010/8/15

Y1 - 2010/8/15

N2 - The search for cancer cell-specific targets suffers from a lack of integrative approaches that take into account the relative contributions of several mechanisms or pathways involved in cell death. A systematic experimental and computational comparison of murine glioma cells with astrocytes, their nontransformed counterparts, identified differences in the sphingolipid (SL) rheostat linked to an increased lysosomal instability in glioma cells. In vitro and in silico analyses indicate that sphingosine metabolized in lysosomes was preferentially recycled into ceramide, the prodeath member of the rheostat, in astrocytes. In glioma cells, it preferentially was used for production of the prosurvival sphingosine-1-phosphate (S1P). A combination of tumor necrosis factor alpha (TNF-α), lipopolysaccharide (LPS), and interferon gamma (IFN-γ) strongly decreased S1P production that resulted in abnormal lysosome enlargement and cell death associated with mitochondrial dysfunction of glioma cells only. Lack of intracellular S1P in glioma cells was concomitant with protein and lipid accumulation in enlarged lysosomes, indicating a blockade in lysosome recycling, and hence a role for S1P in membrane trafficking. A pharmacological sphingosine kinase inhibitor efficiently replaced the TNF-α, LPS, and IFN-γ combination and killed murine and human glioma cells without affecting astrocytes. Our study provides evidence for a novel mechanism of lysosomal death dependent upon the SL rheostat that can be specifically triggered in glioma cells. It further strengthens the potential of cancer therapies based on specific ceramide pathway alterations.

AB - The search for cancer cell-specific targets suffers from a lack of integrative approaches that take into account the relative contributions of several mechanisms or pathways involved in cell death. A systematic experimental and computational comparison of murine glioma cells with astrocytes, their nontransformed counterparts, identified differences in the sphingolipid (SL) rheostat linked to an increased lysosomal instability in glioma cells. In vitro and in silico analyses indicate that sphingosine metabolized in lysosomes was preferentially recycled into ceramide, the prodeath member of the rheostat, in astrocytes. In glioma cells, it preferentially was used for production of the prosurvival sphingosine-1-phosphate (S1P). A combination of tumor necrosis factor alpha (TNF-α), lipopolysaccharide (LPS), and interferon gamma (IFN-γ) strongly decreased S1P production that resulted in abnormal lysosome enlargement and cell death associated with mitochondrial dysfunction of glioma cells only. Lack of intracellular S1P in glioma cells was concomitant with protein and lipid accumulation in enlarged lysosomes, indicating a blockade in lysosome recycling, and hence a role for S1P in membrane trafficking. A pharmacological sphingosine kinase inhibitor efficiently replaced the TNF-α, LPS, and IFN-γ combination and killed murine and human glioma cells without affecting astrocytes. Our study provides evidence for a novel mechanism of lysosomal death dependent upon the SL rheostat that can be specifically triggered in glioma cells. It further strengthens the potential of cancer therapies based on specific ceramide pathway alterations.

KW - Astrocyte

KW - Ceramide

KW - Glioma

KW - Mathematical model

KW - Sphingosine-1-phosphate

KW - Toxicity

UR - http://www.scopus.com/inward/record.url?scp=77956505606&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956505606&partnerID=8YFLogxK

U2 - 10.1002/glia.21013

DO - 10.1002/glia.21013

M3 - Article

VL - 58

SP - 1364

EP - 1383

JO - GLIA

JF - GLIA

SN - 0894-1491

IS - 11

ER -